VolitionRx (VNRX) Competitors

VolitionRx (NYSE:VNRX) and Genfit (NASDAQ:GNFT) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.

Does the MarketBeat Community believe in VNRX or GNFT?

Genfit received 54 more outperform votes than VolitionRx when rated by MarketBeat users. Likewise, 69.70% of users gave Genfit an outperform vote while only 20.83% of users gave VolitionRx an outperform vote.

Company	Underperform	Outperform
VolitionRx	Outperform Votes 15 20.83%	Underperform Votes 57 79.17%
Genfit	Outperform Votes 69 69.70%	Underperform Votes 30 30.30%

Do analysts prefer VNRX or GNFT?

VolitionRx presently has a consensus target price of $3.50, suggesting a potential upside of 522.33%. Genfit has a consensus target price of $13.00, suggesting a potential upside of 205.88%. Given VolitionRx's higher probable upside, analysts clearly believe VolitionRx is more favorable than Genfit.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VolitionRx	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Genfit	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders & institutionals believe in VNRX or GNFT?

8.1% of VolitionRx shares are held by institutional investors. Comparatively, 2.2% of Genfit shares are held by institutional investors. 10.4% of VolitionRx shares are held by insiders. Comparatively, 4.2% of Genfit shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has stronger valuation & earnings, VNRX or GNFT?

Genfit has higher revenue and earnings than VolitionRx.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VolitionRx	$1.31M	44.28	-$35.32M	-$0.27	-2.08
Genfit	$67.00M	3.17	-$31.27M	N/A	N/A

Is VNRX or GNFT more profitable?

Genfit has a net margin of 0.00% compared to VolitionRx's net margin of -2,321.14%.

Company	Net Margins	Return on Equity	Return on Assets
VolitionRx	-2,321.14%	N/A	-163.39%
Genfit	N/A	N/A	N/A

Does the media refer more to VNRX or GNFT?

In the previous week, VolitionRx had 3 more articles in the media than Genfit. MarketBeat recorded 6 mentions for VolitionRx and 3 mentions for Genfit. Genfit's average media sentiment score of 1.53 beat VolitionRx's score of 0.75 indicating that Genfit is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VolitionRx	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Genfit	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has more volatility & risk, VNRX or GNFT?

VolitionRx has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Genfit has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.

Summary

Genfit beats VolitionRx on 8 of the 15 factors compared between the two stocks.